Viridian Therapeutics Inc. (VRDN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 662 |
| % of all portfolios: | 0.011% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
3 |
$30,616,312 |
| Sells |
0 |
$0 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 30 Sep 2024 |
BEETHAM THOMAS W. |
Chief Operating Officer |
27 Sep 2024 |
5,000 |
23.41 |
117,050 |
| 30 Sep 2024 |
MAHONEY STEPHEN F. |
President and CEO |
27 Sep 2024 |
21,400 |
23.33 |
499,262 |
| 17 Sep 2024 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director , 10% |
13 Sep 2024 |
1,600,000 |
18.75 |
30,000,000 |
| 24 Jan 2024 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director , 10% |
22 Jan 2024 |
476,190 |
21.00 |
9,999,990 |
| 12 Apr 2023 |
MYERS SCOTT DUNSETH |
Chief Executive Officer |
12 Apr 2023 |
4,000 |
25.37 |
101,479 |
| 13 Mar 2023 |
MYERS SCOTT DUNSETH |
Chief Executive Officer |
13 Mar 2023 |
5,500 |
29.15 |
160,324 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock